Intrinsic Value of S&P & Nasdaq Contact Us

electroCore, Inc. ECOR NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score
45/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

electroCore, Inc. (ECOR) — Analyst outlook / Analyst consensus target is. Based on 6 analyst ratings, the consensus is bullish — 3 Buy, 3 Hold.

Analysts estimate Earnings Per Share (EPS) of $-1.50 and revenue of $0.03B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-1.59 vs est $-1.50 (missed -5.9%). 2025: actual $-1.65 vs est $-1.72 (beat +4.3%). Analyst accuracy: 95%.

ECOR Analyst Ratings

Buy
6
Ratings
3 Buy
3 Hold
Based on 6 analysts giving stock ratings to electroCore, Inc. in the past 3 months
Rating breakdown
Buy
3 50%
Hold
3 50%
50%
Buy
3 analysts
50%
Hold
3 analysts
0%
Sell
0 analysts

EPS Estimates — ECOR

95%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual –$1.59 vs Est –$1.50 ▼ 5.5% off
2025 Actual –$1.65 vs Est –$1.72 ▲ 4.5% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.

Revenue Estimates — ECOR

100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.025B vs Est $0.025B ▼ 0.0% off
2025 Actual $0.032B vs Est $0.032B ▲ 0.3% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message